One Biosciences
One Biosciences leverages single-cell analysis to power the next generation of precision medicine. By combining deep wet-lab expertise with proprietary AI-driven computational models, the company supports pharma and biotech partners sharpen target selection, prioritize indications, and accelerate the discovery of predictive biomarkers – ultimately boosting clinical trial success rates. Its platform enables more precise therapy selection, improving patient outcomes across difficult-to-treat diseases.
